GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Plat | decreases activity | EXP | | 6480464 | CTD | Dexamethasone results in decreased activity of PLAT protein | PMID:3127913 | Plat | multiple interactions | EXP | | 6480464 | CTD | Dexamethasone inhibits the reaction [IL1B protein results in increased activity of PLAT protein]; Dexamethasone inhibits the reaction [IL1B protein results in increased expression of PLAT mRNA]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased expression of PLAT mRNA]]; RU 43044 inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased expression of PLAT mRNA]] | PMID:15963473 | Plat | decreases activity | ISO | PLAT (Homo sapiens) | 6480464 | CTD | Dexamethasone results in decreased activity of PLAT protein | PMID:1656149 | Plat | decreases expression | ISO | PLAT (Homo sapiens) | 6480464 | CTD | Dexamethasone results in decreased expression of PLAT mRNA | PMID:25047013 | Plat | multiple interactions | ISO | Plat (Mus musculus) | 6480464 | CTD | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PLAT mRNA | PMID:16054899 | Plat | multiple interactions | ISO | PLAT (Homo sapiens) | 6480464 | CTD | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of PLAT mRNA | PMID:28628672 | |
Go Back to source page | Continue to Ontology report |